Showing results (61-70 of 137) with videos related to
Sort By:
Pageof 14
Targeted Oncology|September 18, 2016
Regorafenib in the Real-Life Clinical Practice: Data from the Czech RegistryKaterina Kopeckova, Tomas Buchler, Zbynek Bortlicek, et al.BMC Cancer|June 3, 2014
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysisTomas Buchler, Tomas Pavlik, Bohuslav Melichar, et al.Targeted Oncology|February 14, 2020
Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical PracticeTomas Buchler, Igor Kiss, Jana Hornova, et al.Mutagenesis|July 2, 2021
Mutational landscape of plasma cell-free DNA identifies molecular features associated with therapeutic response in patients with colon cancer. A pilot studyKlara Cervena, Barbara Pardini, Marketa Urbanova, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 15, 2018
Association of the combined parameters including the frequency of primary cilia, CD8+ tumor infiltrating lymphocytes and PD-1 expression with the outcome in intestinal cancerJosef Dvorak, Dimitar Hadzi Nikolov, Ladislav Dusek, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 13, 2016
Prognostic significance of the frequency of primary cilia in cells of small bowel and colorectal adenocarcinomaJosef Dvorak, Dimitar Hadzi Nikolov, Ladislav Dusek, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 25, 2019
Negative prognostic significance of primary cilia, CD8+ tumor infiltrating lymphocytes and PD1+ cells expression in clear cell renal cancerAneta Rozsypalova, Blanka Rosova, Alzbeta Filipova, et al.Anticancer Research|September 16, 2016
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer PatientsIgor Kiss, Jitka Mlcochova, Zbynek Bortlicek, et al.Carcinogenesis|November 3, 2016
Polymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patientsVeronika Vymetalkova, Barbara Pardini, Fabio Rosa, et al.Neoplasma|January 22, 2024
Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancerBlanka Rosova, Jan Proks, Alzbeta Filipova, et al.Pageof 14